{"id":"https://openalex.org/W4286294252","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.4139","title":"Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.","display_name":"Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4286294252","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.4139"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.4139","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.4139","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.4139","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015026500","display_name":"Katherine E. Poruk","orcid":"https://orcid.org/0000-0002-2170-1688","observed_orcids":["https://orcid.org/0000-0002-2170-1688"]},"institutions":[{"id":"https://openalex.org/I179638627","display_name":"Cancer Treatment Centers of America","ror":"https://ror.org/045ns1x37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I179638627"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine E Poruk","raw_affiliation_strings":["Cancer Treatment Centers of America, Part of City of Hope, Newnan, GA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Treatment Centers of America, Part of City of Hope, Newnan, GA;","institution_ids":["https://openalex.org/I179638627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060037511","display_name":"Amber Moran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I179638627","display_name":"Cancer Treatment Centers of America","ror":"https://ror.org/045ns1x37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I179638627"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amber Moran","raw_affiliation_strings":["Cancer Treatment Centers of America, Part of City of Hope, Boca Raton, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Treatment Centers of America, Part of City of Hope, Boca Raton, FL;","institution_ids":["https://openalex.org/I179638627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046832911","display_name":"Vicki Doctor","orcid":"https://orcid.org/0000-0003-3028-7404","observed_orcids":["https://orcid.org/0000-0003-3028-7404"]},"institutions":[{"id":"https://openalex.org/I179638627","display_name":"Cancer Treatment Centers of America","ror":"https://ror.org/045ns1x37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I179638627"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vicki Doctor","raw_affiliation_strings":["Cancer Treatment Centers of America, Part of City of Hope, Boca Raton, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Treatment Centers of America, Part of City of Hope, Boca Raton, FL;","institution_ids":["https://openalex.org/I179638627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062006821","display_name":"Julia Andrea Elvin","orcid":"https://orcid.org/0000-0001-9476-9563","observed_orcids":["https://orcid.org/0000-0001-9476-9563"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia Andrea Elvin","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110628655","display_name":"Saba Radhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I926076166","display_name":"Texas Tech University Health Sciences Center","ror":"https://ror.org/033ztpr93","country_code":"US","type":"education","lineage":["https://openalex.org/I926076166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saba Radhi","raw_affiliation_strings":["Texas Tech University Health Sciences Center, Lubbock, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Tech University Health Sciences Center, Lubbock, TX;","institution_ids":["https://openalex.org/I926076166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060268370","display_name":"Arturo Loaiza\u2010Bonilla","orcid":"https://orcid.org/0000-0002-3655-9602","observed_orcids":["https://orcid.org/0000-0002-3655-9602"]},"institutions":[{"id":"https://openalex.org/I179638627","display_name":"Cancer Treatment Centers of America","ror":"https://ror.org/045ns1x37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I179638627"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arturo Loaiza-Bonilla","raw_affiliation_strings":["Cancer Treatment Centers of America, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Treatment Centers of America, Philadelphia, PA;","institution_ids":["https://openalex.org/I179638627"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052993364","display_name":"Julian C. Schink","orcid":"https://orcid.org/0000-0002-7864-8152","observed_orcids":["https://orcid.org/0000-0002-7864-8152"]},"institutions":[{"id":"https://openalex.org/I179638627","display_name":"Cancer Treatment Centers of America","ror":"https://ror.org/045ns1x37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I179638627"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julian C. Schink","raw_affiliation_strings":["Cancer Treatment Centers of America, Part of City of Hope, Zion, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Treatment Centers of America, Part of City of Hope, Zion, IL;","institution_ids":["https://openalex.org/I179638627"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012517342","display_name":"Maurie M. Markman","orcid":"https://orcid.org/0000-0001-5681-0393","observed_orcids":["https://orcid.org/0000-0001-5681-0393"]},"institutions":[{"id":"https://openalex.org/I179638627","display_name":"Cancer Treatment Centers of America","ror":"https://ror.org/045ns1x37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I179638627"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maurie Markman","raw_affiliation_strings":["Cancer Treatment Centers of America, Part of City of Hope, Boca Raton, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Treatment Centers of America, Part of City of Hope, Boca Raton, FL;","institution_ids":["https://openalex.org/I179638627"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"4139","last_page":"4139"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/stage-iv","display_name":"stage IV","score":0.703000009059906},{"id":"https://openalex.org/keywords/comprehensive-genomic-profiling","display_name":"comprehensive genomic profiling","score":0.8840000033378601},{"id":"https://openalex.org/keywords/actionable-mutations","display_name":"actionable mutations","score":0.5540000200271606},{"id":"https://openalex.org/keywords/kras","display_name":"KRAS","score":0.8600000143051147},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":1.0},{"id":"https://openalex.org/keywords/cdkn2a","display_name":"CDKN2A","score":0.9900000095367432},{"id":"https://openalex.org/keywords/smad4","display_name":"SMAD4","score":0.9819999933242798},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.8339999914169312},{"id":"https://openalex.org/keywords/microsatellite-instability","display_name":"microsatellite instability","score":0.9589999914169312},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5950000286102295},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5460000038146973},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.6230000257492065},{"id":"https://openalex.org/keywords/folfirinox","display_name":"FOLFIRINOX","score":0.8190000057220459},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9610000252723694},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.5270000100135803},{"id":"https://openalex.org/keywords/molecular-subtypes","display_name":"molecular subtypes","score":0.40299999713897705},{"id":"https://openalex.org/keywords/metastatic-pancreatic-cancer","display_name":"metastatic pancreatic cancer","score":0.382999986410141},{"id":"https://openalex.org/keywords/treatment-decision-making","display_name":"treatment decision-making","score":0.33899998664855957}],"concepts":[{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.8688817620277405},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8463972806930542},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8215160965919495},{"id":"https://openalex.org/C2777148230","wikidata":"https://www.wikidata.org/wiki/Q17144959","display_name":"FOLFIRINOX","level":5,"score":0.6805894374847412},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6635650396347046},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6364601254463196},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6227754950523376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.596342921257019},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.5022084712982178},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4177634119987488},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4142100512981415},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.34045180678367615},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.08821362257003784},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.4139","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.4139","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.4139","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4286296044","https://openalex.org/W4306177494","https://openalex.org/W2913123776","https://openalex.org/W2892035549","https://openalex.org/W4411429403","https://openalex.org/W7168768671","https://openalex.org/W2103030235","https://openalex.org/W2766495528","https://openalex.org/W7169129443","https://openalex.org/W7170190757"],"abstract_inverted_index":{"4139":[0],"Background:":[1],"Curative":[2],"treatment":[3,75,105],"of":[4,38,54,95,176,207,384,397],"pancreatic":[5],"adenocarcinoma":[6],"(PDAC)":[7],"remains":[8,32],"a":[9,67,145,342,381,416],"challenge,":[10],"as":[11,114,294],"most":[12,180],"patients":[13,58,85,157,233,245,290,340,388,407],"present":[14,52],"with":[15,86,92,116,130,160,234,311,323,332,341,351,390,412,419],"advanced":[16],"disease":[17],"that":[18],"has":[19],"spread":[20],"to":[21,44,71,97,409,426],"other":[22],"organs.":[23],"The":[24,179],"main":[25],"opportunity":[26],"for":[27,29,48,104,232,274,288,430],"cure":[28],"these":[30],"individuals":[31],"systemic":[33],"therapy.":[34],"An":[35],"improved":[36],"understanding":[37],"the":[39,208,253,338,431],"tumor":[40,102],"biology":[41],"is":[42,424],"needed":[43,425],"appropriately":[45],"target":[46],"therapies":[47,118,356,429],"individual":[49],"patients.":[50,178],"We":[51],"cohort":[53],"Stage":[55,87,385],"IV":[56,88,386],"PDAC":[57,89,177,387,436],"who":[59],"underwent":[60,90],"prospective":[61],"comprehensive":[62],"genomic":[63,73,109,182],"profiling":[64],"(CGP)":[65],"in":[66,171,185,205,221,236,261,320,395,435],"national":[68],"cancer":[69],"network":[70],"evaluate":[72],"mutations,":[74],"patterns":[76],"and":[77,82,125,144,200,268,291,302,374],"survival.":[78,442],"Methods:":[79],"Between":[80],"2013":[81],"2021,":[83],"458":[84],"CGP":[91],"hybrid":[93],"capture":[94],"up":[96],"406":[98],"cancer-related":[99],"genes":[100,212],"on":[101,252,440],"tissue":[103],"decision-making.":[106],"Clinically":[107],"relevant":[108],"alterations":[110,183],"(CRGA)":[111],"were":[112,127,147,158,169,184,349,393],"defined":[113],"associated":[115,310,331],"targeted":[117,428],"or":[119,166,217,238,344],"mechanism-driven":[120],"clinical":[121],"trials.":[122],"Patient":[123],"demographics":[124],"outcomes":[126],"retrospectively":[128],"reviewed":[129],"IRB":[131],"approval.":[132],"Results:":[133],"Median":[134,150,226],"patient":[135,279],"age":[136],"at":[137],"presentation":[138],"was":[139,153,219,229,272,280,286,292,308,318,329],"59":[140],"years":[141],"(range,":[142],"26-84)":[143],"majority":[146],"male":[148],"(55%).":[149],"overall":[151,227,441],"survival":[152,228],"15":[154],"months.":[155],"Most":[156,406],"treated":[159,350,411],"first":[161],"line":[162],"chemotherapy,":[163],"predominantly":[164],"gemcitabine":[165],"FOLFIRINOX.":[167],"GA":[168,392],"identified":[170,220,394],"98%":[172,396],"(n":[173,223,359,363,367,371,376],"=":[174,224,314,335,360,364,368,372,377],"447)":[175],"common":[181,433],"KRAS":[186,237],"(85%),":[187],"TP53":[188,239],"(75%),":[189],"CDKN2A":[190],"(52%),":[191],"SMAD4":[192],"(21%),":[193],"ARID1A":[194],"(9%),":[195],"BRCA2":[196,345],"(5%),":[197],"RNF43":[198],"(4%),":[199],"BRCA1":[201,343],"(1%).":[202,305],"A":[203],"mutation":[204,250],"one":[206,278],"four":[209],"commonly":[210,354],"mutated":[211],"(":[213],"KRAS,":[214],"TP53,":[215],"CDKN2A,":[216],"SMAD4)":[218],"94%":[222],"426).":[225],"significantly":[230],"worse":[231],"mutations":[235,260,434],"(both,":[240],"P":[241],"<":[242],"0.05).":[243],"185":[244],"(40%)":[246],"had":[247,402],"an":[248,403],"actionable":[249,404],"based":[251],"Know":[254],"Your":[255],"Tumor":[256,282],"registry":[257],"trial,":[258],"including":[259],"BRCA1,":[262],"BRCA2,":[263],"BRAF,":[264],"CHEK2,":[265],"ATM,":[266],"ATK":[267],"STK11.":[269],"MSI":[270],"status":[271,307,317],"noted":[273],"226":[275],"patients;":[276],"only":[277,400],"MSI-high.":[281],"Mutational":[283],"Burden":[284],"(TMB)":[285],"known":[287],"228":[289],"split":[293],"follows:":[295],"199":[296],"TMB-low":[297],"(87%),":[298],"27":[299],"TMB-intermediate":[300],"(12%),":[301],"2":[303],"TMB-high":[304],"TMB":[306],"not":[309,330],"OS":[312,333],"(P":[313,334],"0.21).":[315],"PD-L1":[316,325],"obtained":[319],"20":[321],"patients,":[322],"9":[324],"positive":[326],"(45%);":[327],"this":[328],"0.66).":[336],"Of":[337],"38":[339],"mutation,":[346],"31":[347],"(82%)":[348],"Olaparib.":[352],"Other":[353],"utilized":[355],"included":[357],"Niraparib":[358],"56),":[361],"Regorafenib":[362],"8),":[365,373],"Everolimus":[366],"34),":[369],"Erlotinib":[370],"Cetuximab":[375],"6).":[378],"Conclusions:":[379],"In":[380],"large":[382],"series":[383],"assayed":[389],"CGP,":[391],"tumors":[398],"but":[399],"40%":[401],"mutation.":[405],"continue":[408],"be":[410],"conventional":[413],"chemotherapy":[414],"despite":[415],"sizeable":[417],"group":[418],"targetable":[420],"mutations.":[421],"Further":[422],"work":[423],"identify":[427],"more":[432],"given":[437],"their":[438],"impact":[439]},"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2022-07-21T00:00:00"}